ArticleNeuro-oncology advances

Phase I trial of sargramostim/pelareorep therapy in pediatric patients with recurrent or refractory high-grade brain tumors.

Matthew R Schuelke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.